FY2025 Earnings Forecast for Insmed Issued By HC Wainwright
Insmed Incorporated (NASDAQ:INSM – Free Report) – Analysts at HC Wainwright raised their FY2025 earnings estimates for Insmed in a note issued to investors on Wednesday, June 11th. HC Wainwright analyst A. Fein now expects that the biopharmaceutical company will post earnings of ($5.05) per share for the year, up from their previous forecast of […]
